CLCGY Quote, Financials, Valuation and Earnings

Aspen Pharmacare Holdings has a net margin of -- compared to Clicks Group's net margin of --. Clicks Group's return on equity of 48.74% beat Aspen Pharmacare Holdings's return on equity of 5.16%.

Clicks Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Aspen Pharmacare Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Clicks Group has higher upside potential than Aspen Pharmacare Holdings, analysts believe Clicks Group is more attractive than Aspen Pharmacare Holdings.

Clicks Group has a beta of 0.763, which suggesting that the stock is 23.696% less volatile than S&P 500. In comparison Aspen Pharmacare Holdings has a beta of 1.121, suggesting its more volatile than the S&P 500 by 12.142%.

Clicks Group has a quarterly dividend of $0.23 per share corresponding to a yield of 1.89%. Aspen Pharmacare Holdings offers a yield of 2.24% to investors and pays a quarterly dividend of $0.21 per share. Clicks Group pays -- of its earnings as a dividend. Aspen Pharmacare Holdings pays out 34.63% of its earnings as a dividend. Aspen Pharmacare Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Clicks Group quarterly revenues are --, which are smaller than Aspen Pharmacare Holdings quarterly revenues of --. Clicks Group's net income of -- is lower than Aspen Pharmacare Holdings's net income of --. Notably, Clicks Group's price-to-earnings ratio is 31.09x while Aspen Pharmacare Holdings's PE ratio is 15.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clicks Group is 1.94x versus 1.72x for Aspen Pharmacare Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Life Healthcare Group Holdings has a net margin of -- compared to Clicks Group's net margin of --. Clicks Group's return on equity of 48.74% beat Life Healthcare Group Holdings's return on equity of 30.26%.

Clicks Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Life Healthcare Group Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Clicks Group has higher upside potential than Life Healthcare Group Holdings, analysts believe Clicks Group is more attractive than Life Healthcare Group Holdings.

Clicks Group has a beta of 0.763, which suggesting that the stock is 23.696% less volatile than S&P 500. In comparison Life Healthcare Group Holdings has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.635%.

Clicks Group has a quarterly dividend of $0.23 per share corresponding to a yield of 1.89%. Life Healthcare Group Holdings offers a yield of 3.16% to investors and pays a quarterly dividend of $0.07 per share. Clicks Group pays -- of its earnings as a dividend. Life Healthcare Group Holdings pays out 196.23% of its earnings as a dividend.

Clicks Group quarterly revenues are --, which are smaller than Life Healthcare Group Holdings quarterly revenues of --. Clicks Group's net income of -- is lower than Life Healthcare Group Holdings's net income of --. Notably, Clicks Group's price-to-earnings ratio is 31.09x while Life Healthcare Group Holdings's PE ratio is 4.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clicks Group is 1.94x versus 0.92x for Life Healthcare Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Institute of Biomedical Research has a net margin of -- compared to Clicks Group's net margin of --. Clicks Group's return on equity of 48.74% beat Institute of Biomedical Research's return on equity of --.

Clicks Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Institute of Biomedical Research has an analysts' consensus of -- which suggests that it could fall by --. Given that Clicks Group has higher upside potential than Institute of Biomedical Research, analysts believe Clicks Group is more attractive than Institute of Biomedical Research.

Clicks Group has a beta of 0.763, which suggesting that the stock is 23.696% less volatile than S&P 500. In comparison Institute of Biomedical Research has a beta of 2.581, suggesting its more volatile than the S&P 500 by 158.057%.

Clicks Group has a quarterly dividend of $0.23 per share corresponding to a yield of 1.89%. Institute of Biomedical Research offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clicks Group pays -- of its earnings as a dividend. Institute of Biomedical Research pays out -- of its earnings as a dividend.

Clicks Group quarterly revenues are --, which are smaller than Institute of Biomedical Research quarterly revenues of --. Clicks Group's net income of -- is lower than Institute of Biomedical Research's net income of --. Notably, Clicks Group's price-to-earnings ratio is 31.09x while Institute of Biomedical Research's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clicks Group is 1.94x versus -- for Institute of Biomedical Research. Usually stocks with elevated PS ratios are considered overvalued.

Netcare has a net margin of -- compared to Clicks Group's net margin of --. Clicks Group's return on equity of 48.74% beat Netcare's return on equity of 13.51%.

Clicks Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Netcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Clicks Group has higher upside potential than Netcare, analysts believe Clicks Group is more attractive than Netcare.

Clicks Group has a beta of 0.763, which suggesting that the stock is 23.696% less volatile than S&P 500. In comparison Netcare has a beta of 0.083, suggesting its less volatile than the S&P 500 by 91.675%.

Clicks Group has a quarterly dividend of $0.23 per share corresponding to a yield of 1.89%. Netcare offers a yield of 4.5% to investors and pays a quarterly dividend of $0.16 per share. Clicks Group pays -- of its earnings as a dividend. Netcare pays out -- of its earnings as a dividend.

Clicks Group quarterly revenues are --, which are smaller than Netcare quarterly revenues of --. Clicks Group's net income of -- is lower than Netcare's net income of --. Notably, Clicks Group's price-to-earnings ratio is 31.09x while Netcare's PE ratio is 13.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clicks Group is 1.94x versus 0.74x for Netcare. Usually stocks with elevated PS ratios are considered overvalued.